Insider trades

Sanj K. Patel, Chairman of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $39.4M. The latest trade was on 06/01.

Sanj K. Patel

Chairman & CEO
First filing
23/03/20
Trades
151 trades
Buys / sales
0 / 28
12-month net buying
−$39.4M
Last trade
06/01

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan05/0105/0148,565 sh$54.02$2,623,481.3−100.0%
KNSA
Open-market sale10b5-1 plan04/28–04/3004/30508,339 sh6 trades$51.96avg.$26,415,228.13−100.0%
Open-market sale10b5-1 plan04/0604/087,278 sh$50.01$363,972.78−100.0%
KNSA
Open-market sale10b5-1 plan25/10/20–25/10/2225/10/22257,969 sh4 trades$38.86avg.$10,023,531.59−69.8%
KNSA
Open-market sale10b5-1 plan25/05/23–25/05/2825/05/2886,270 sh3 trades$27.24avg.$2,349,981.45−47.2%
Open-market sale10b5-1 plan25/05/2025/05/222,349 sh$27.02$63,469.98−2.4%
Open-market sale10b5-1 plan25/05/1325/05/152,872 sh$27.03$77,630.16−2.9%
KNSA
Open-market sale10b5-1 plan25/05/07–25/05/0925/05/098,095 sh3 trades$27.04avg.$218,866.45−7.7%
Open-market sale10b5-1 plan24/11/0624/11/0889,561 sh$23.00$2,059,903−53.0%
KNSA
Open-market sale10b5-1 plan24/07/2324/07/25136,124 sh3 trades$25.65avg.$3,491,947.24−68.4%
Open-market sale10b5-1 plan24/03/0724/03/1165,012 sh$21.02$1,366,552.24−100.0%
KNSA
Open-market sale10b5-1 plan24/03/04–24/03/0624/03/0618,324 sh3 trades$21.34avg.$391,055.86−22.0%